Augusto P. Antoniazzi

Barretos, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer.

Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer.

Journal: The New England journal of medicine

Published: December 10, 2025

Brazilian biorepository to support genome-wide association studies of colorectal, breast, and cervical cancer.

Brazilian biorepository to support genome-wide association studies of colorectal, breast, and cervical cancer.

Journal: iScience

Published: September 24, 2025

KRAS-G12C: The neglected biomarker to detect patients with MUTYH-associated polyposis.

KRAS-G12C: The neglected biomarker to detect patients with MUTYH-associated polyposis.

Journal: International journal of cancer

Published: June 16, 2025

Establishment and molecular profiling of a PDX model of a metachronous brain tumor in a patient with constitutional mismatch repair deficiency with biallelic MSH6 variant.

Establishment and molecular profiling of a PDX model of a metachronous brain tumor in a patient with constitutional mismatch repair deficiency with biallelic MSH6 variant.

Journal: Animal models and experimental medicine

Published: April 27, 2025

Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls.

Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls.

Journal: Gut

Published: December 16, 2024

High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population.

High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population.

Journal: Frontiers in oncology

Published: June 13, 2023

Disruptive and Truncating TP53 Mutations Are Associated with African-Ancestry and Worse Prognosis in Brazilian Patients with Lung Adenocarcinoma.

Disruptive and Truncating TP53 Mutations Are Associated with African-Ancestry and Worse Prognosis in Brazilian Patients with Lung Adenocarcinoma.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: October 27, 2022

Genomic profile of two Brazilian choroid plexus tumors by whole-exome sequencing.

Genomic profile of two Brazilian choroid plexus tumors by whole-exome sequencing.

Journal: Cold Spring Harbor molecular case studies

Published: September 23, 2022

Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country.

Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country.

Journal: Frontiers in oncology

Published: May 23, 2022

Showing 1-9 of 9

Last Updated: 09/26/2026